- CEO
- David Layton
- Sector
- Finance
- Industry
- Investment managers
- Address
- Luxembourg Luxembourg
- Business
- Partners Group Direct Equity V (EUR) S.C.A. SICAV-RAIF is a Luxembourg-based reserved alternative investment fund specializing in direct private equity investments, buyout transactions, and growth capital deployment across global markets. Established in 2022 and headquartered in Luxembourg City, Luxembourg, the fund operates as a specialized investment company with variable capital managed by Partners Group, a global private markets investment management firm headquartered in Baar-Zug, Switzerland. The fund provides comprehensive private equity investment solutions, with core offerings and product capabilities including direct equity investments in mid- to large-cap market leaders; control and co-control buyout financing; growth equity provision; bespoke institutional co-investment structuring; hands-on operational value creation and platform building; corporate carve-out and succession financing; cross-border market expansion capital; and thematic portfolio management aligned with long-term macroeconomic trends. Its investment portfolio spans four core industry sectors: Technology, encompassing enterprise software, digital infrastructure, and IT services; Health and Life, covering healthcare services, medical technology, and life sciences; Goods and Products, comprising specialized manufacturing, consumer products, and supply chain logistics; and Services, including business-to-business services, financial services, and testing, inspection, and certification solutions. The fund serves institutional investors, sovereign wealth funds, pension schemes, insurance enterprises, and qualified private wealth clients across North America, Europe, and the Asia-Pacific region. In recent major developments, the fund and its investment manager have actively accelerated capital deployment through direct platform buyout acquisitions across target verticals such as digital transformation services, mission-critical healthcare solutions, and specialized industrial technology; completed strategic add-on acquisitions to drive inorganic growth across underlying portfolio companies; expanded institutional co-investment partnerships to capture large-scale direct market opportunities; and integrated artificial intelligence and digital operating playbooks across portfolio assets to optimize operational efficiency and commercial performance.